Health Union, the leading digital health company for online community-based activation and data, has launched a new community dedicated to supporting individuals affected by opioid use disorder (OUD).

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (Active ...

The first round of opioid remediation grants from the Fairbanks North Star Borough provides three ways to address drug abuse.

Over a decade spent treating and researching substance use disorders taught one researcher that the overdose epidemic is a ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...

Adial Pharmaceuticals (ADIL) announced patent number 12,221,654 was issued on February 11, 2025, by the United States Patent and Trademark ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...

Opioid use disorder can affect people of all ages, including older adults. In two clinical trials, Journavax demonstrated statistically significant pain reduction in patients who had routine abdominal ...